Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

United States Post-Marketing Observational Cardiovascular Safety Study in Patients Taking Naloxegol

NCT02813356 is registered in ClinicalTrials.gov with Valinor Pharma LLC as lead sponsor.

NCT NCT02813356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02813356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
United States Post-Marketing Observational Cardiovascular Safety Study in Patients Taking Naloxegol
Lead sponsor
Valinor Pharma LLC
Phase
Observational
Overall status
Unknown status
Start date
June 24, 2016
Completion date
December 31, 2023
Enrollment
8,800 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

opioid induced constipation